Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seqirus
With
Novartis Vaccines
Age
0–5
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Children, males and females, healthy or at high risk of complications from influenza, between ≥6 months to \<72 months of age
Documented consent provided by the subject's parent(s)/legal guardian(s)
Subjects and/or subject's parent(s)/legal guardian(s) able to comply with all study procedures.
You may not be if
Children with history of allergy to vaccine components.
Additional eligibility criteria may be discussed by contacting the site
Clareo Health | Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.
